Published in Q J Med on January 01, 1984
New features of disease after diagnosis in 6 forms of systemic vasculitis. J Rheumatol (2013) 1.59
Update on diffuse alveolar hemorrhage and pulmonary vasculitis. Immunol Allergy Clin North Am (2012) 1.07
Clinical features and outcomes of microscopic polyangiitis in Korea. J Korean Med Sci (2009) 1.03
Anti-plasminogen antibodies compromise fibrinolysis and associate with renal histology in ANCA-associated vasculitis. J Am Soc Nephrol (2010) 0.95
Prognostic factors for hospital mortality and ICU admission in patients with ANCA-related pulmonary vasculitis. Am J Med Sci (2008) 0.94
Prognostic factors in Wegener's granulomatosis. Postgrad Med J (1993) 0.90
Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea. Rheumatol Int (2011) 0.85
Renal vasculitis: a review. J R Soc Med (1985) 0.79
Renal micropolyarteritis. Br Med J (Clin Res Ed) (1987) 0.75
Microscopic polyangiitis histologically confirmed by biopsy from nasal cavity and paranasal sinuses: a case report. Rheumatol Int (2006) 0.75
Microscopic polyarteritis: clinical features and treatment. Postgrad Med J (1989) 0.75
Vasculitis and rapidly progressive glomerulonephritis in the elderly. Postgrad Med J (1996) 0.75
Amphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitis. Clin Exp Immunol (2001) 0.75
The aetiology and pathogenesis of major systemic vasculitides. Postgrad Med J (1986) 0.75
Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis (1988) 9.38
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Haematemesis and melaena, with special reference to factors influencing the outcome. Br Med J (1970) 4.31
An Unusual Organism (Micrococcus zymogenes) in a Case of Malignant Endocarditis. Proc R Soc Med (1912) 4.13
Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease. QJM (2002) 3.09
Successful treatment of middle aged and elderly patients with end stage renal disease. Br Med J (Clin Res Ed) (1983) 2.88
Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia. J Clin Invest (1974) 2.81
Schönlein-Henoch nephritis. Q J Med (1972) 2.64
Complement studies in membrano-proliferative glomerulonephritis. Clin Exp Immunol (1972) 2.60
10 years' experience with regular haemodialysis and renal transplantation. Arch Dis Child (1980) 2.56
The complement abnormalities of lipodystrophy. N Engl J Med (1976) 2.40
The vascular tree of the haemal node in the rat. J Anat (1969) 2.40
The simple assessment of selectivity in heavy proteinuria. Lancet (1966) 2.36
Why the persistently high mortality in acute renal failure. Lancet (1972) 2.32
Prognosis of Henoch-Schönlein nephritis in children. Br Med J (1977) 2.32
Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome. Br Med J (1966) 2.31
Gastric cancer simulating benign gastric ulcer. Br J Surg (1969) 2.27
The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg (1985) 2.20
Targeted disruption of semaphorin 3C leads to persistent truncus arteriosus and aortic arch interruption. Development (2001) 2.15
Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ (1995) 2.10
Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis. Br Med J (1973) 2.07
Serum immune complexes and disease activity in lupus nephritis. Lancet (1977) 2.07
Fatal microcystin intoxication in haemodialysis unit in Caruaru, Brazil. Lancet (1998) 2.06
Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci U S A (1991) 2.05
Holoprosencephaly (lobar form) associated with bilateral vocal cord palsy. J Child Neurol (2001) 2.02
Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J Infect Dis (1985) 2.02
Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia. Lancet (1973) 2.00
Cyclophosphamide therapy in the nephrotic syndrome in childhood. Br Med J (1969) 1.99
Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis. Lancet (1973) 1.93
Membranous nephropathy. Long-term follow-up and association with neoplasia. Q J Med (1975) 1.81
In vivo somatic mutations in human lymphocytes frequently result from major gene alterations. Nature (1985) 1.80
Female genital mutilation: a dilemma in child protection. Arch Dis Child (1994) 1.78
Using telemedicine to improve health care in distant areas. Hosp Community Psychiatry (1992) 1.77
Left-to-right atrial shunting after percutaneous mitral valvuloplasty. Incidence and long-term hemodynamic follow-up. Circulation (1990) 1.77
The SF36 as an outcome measure of services for end stage renal failure. Qual Health Care (1998) 1.76
Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction. Hepatology (1988) 1.74
Genetics of classic Alport's syndrome. Lancet (1988) 1.73
Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med (1983) 1.70
THE ORGANIZATION OF SCIENTIFIC MEN. Science (1924) 1.69
Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant (1997) 1.69
Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients. Antimicrob Agents Chemother (1994) 1.69
Studies of serum complement in the hypocomplementaemic nephritides. Clin Exp Immunol (1974) 1.67
Exogenous interferon-gamma immunotherapy for invasive fungal infections in kidney transplant patients. Am J Transplant (2010) 1.66
Chronic dialysis in patients with multiple myeloma and renal failure: a worthwhile treatment. Q J Med (1989) 1.65
Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management. Lancet (1983) 1.64
Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis. Lancet (1974) 1.62
Can immunosuppressive drugs slow the progression of IgA nephropathy? Nephrol Dial Transplant (1995) 1.59
Children referred for acute dialysis. Arch Dis Child (1971) 1.58
Endogenous complement C3 synthesis in immune complex nephritis. Lancet (1993) 1.57
The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol (1984) 1.55
Murine lupus monoclonal antibodies define five epitopes on two different Sm polypeptides. Immunology (1986) 1.54
Plasma C3 and C4 concentrations in management of glomerulonephritis. Br Med J (1973) 1.53
Gastroscopy with biopsy and cytological sampling under direct vision. Br Med J (1968) 1.53
Ultrastructural pathology of experimental Ebola haemorrhagic fever virus infection. J Pathol (1985) 1.52
Long-term outcome for children with minimal-change nephrotic syndrome. Lancet (1985) 1.52
Phagocytes, lipid-removal and regression of atheroma. J Pathol (1975) 1.51
Tenckhoff catheter replacement or intraperitoneal urokinase: a randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis. Perit Dial Int (1989) 1.49
Anti-ssDNA and antinuclear antibodies in human malaria. Clin Exp Immunol (1982) 1.49
Postanastomotic transplant renal artery stenosis: association with de novo class II donor-specific antibodies. Am J Transplant (2014) 1.49
Genes encoding the beta-chains of HLA-DR7 and HLA-DQw2 define major susceptibility determinants for idiopathic nephrotic syndrome. Clin Sci (Lond) (1990) 1.49
Emergence of resistance to erythromycin and fluoroquinolones in thermotolerant Campylobacter strains isolated from feces 1987-1991. Eur J Clin Microbiol Infect Dis (1992) 1.49
Broadcast television for Doctors-a first evaluation. Br Med J (1966) 1.48
Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts. Leukemia (2002) 1.47
Parathyroidectomy in the treatment of secondary renal hyperparathyroidism. Kidney Int (1973) 1.46
Monoclonal antibodies to the Sjögren's syndrome associated antigen SS-B (La). J Immunol Methods (1985) 1.46
The true clinical significance of renography in nephro-urology. Eur J Nucl Med (1997) 1.46
Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block. Paediatr Anaesth (2004) 1.44
Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol (1990) 1.44
The identification of 2,8-dihydroxyadenine, a new component of urinary stones. Biochem J (1976) 1.43
Migration of cardiac neural crest cells in Splotch embryos. Development (2000) 1.43
In vivo human somatic mutation: frequency and spectrum with age. Mutat Res (1992) 1.42
Magnetic resonance angiography of renal artery stenosis. Clin Radiol (1995) 1.41
Membranoproliferative glomerulonephritis and persistent hypocomplementaemia. Br Med J (1970) 1.41
Stripping of failing haemodialysis catheters using the Ampltaz gooseneck snare. Clin Radiol (1997) 1.40
A review of the literature on cocaine abuse in pregnancy. Nurs Res (1991) 1.40